[artículo] 
inJournal of Clinical Psychopharmacology > Año 2002 - Vol. 22 - No. 3 (Junio) . - pp. 252-256

Título :	High serum creatinine kinase level: possible risk factor for neuroleptic malignant syndrome
Tipo de documento:	texto impreso
Autores:	Haggai Hermesh, Autor ; Iris Manor, Autor ; Roni Shiloh, Autor
Fecha de publicación:	2023
Artículo en la página:	pp. 252-256
Idioma :	Inglés (eng) Idioma original : Inglés (eng)
Palabras clave:	Creatina quinasa, Síndrome Neuroléptico Maligno.
Resumen:	High creatinine kinase (CK) levels and leukocytosis are known to be associated with neuroleptic malignant syndrome (NMS). The authors sought to determine if their presence during non-NMS psychotic episodes is predictive of the later development of NMS. Sixteen psychotic inpatients who met the criteria for NMS were included.
Link:	./index.php?lvl=notice_display&id=31063

[artículo] High serum creatinine kinase level: possible risk factor for neuroleptic malignant syndrome [texto impreso] / Haggai Hermesh, Autor ; Iris Manor, Autor ; Roni Shiloh, Autor . - 2023 . - pp. 252-256.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in Journal of Clinical Psychopharmacology > Año 2002 - Vol. 22 - No. 3 (Junio) . - pp. 252-256

Palabras clave:	Creatina quinasa, Síndrome Neuroléptico Maligno.
Resumen:	High creatinine kinase (CK) levels and leukocytosis are known to be associated with neuroleptic malignant syndrome (NMS). The authors sought to determine if their presence during non-NMS psychotic episodes is predictive of the later development of NMS. Sixteen psychotic inpatients who met the criteria for NMS were included.
Link:	./index.php?lvl=notice_display&id=31063